BioIndustry Association Welcomes UK Government Drive to Put Challenge of Antibiotic Resistance on the Global Agenda

Published: Jun 12, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

12 June 2013 -- As the Science Ministers and Presidents of the Science Academies in G8 countries meet today in London to discuss the role of science in tackling global challenges, Steve Bates, BioIndustry Association (BIA) Chief Executive Officer, said:

"The BIA welcomes the fact that the UK government has put this issue of tackling antibiotic resistance on the international agenda. The vibrant UK bioscience base is eager to play its part in addressing this global challenge. UK biotech companies, such as Discuva and Cantab Anti-infectives for example, are using Biomedical Catalyst funding to discover and develop new antibiotic classes for Gram-negative bacteria.

"However, getting the incentives right globally for investment in this is essential. For instance, we need incentives for pharmaceutical companies to develop drugs that will only be used infrequently and sparingly rather than paid for every pill used. I hope the discussion today explores new concepts around this agenda to enable commercial companies to fully engage on this vital challenge for society."

For further information, please contact Robert Winder, Head of Communications,, 020 7630 2191; mobile 07825 942 934.

BioIndustry Association

Founded over 20 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative enterprises involved in UK bioscience. Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector. The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators to patient groups and the media. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives. For further information, please go to

Help employers find you! Check out all the jobs and post your resume.

Back to news